Bristol-Myers Squibb: The Winning Streak Continues (BMY)
Shares of Bristol-Myers Squibb (NYSE:BMY) traded at a new 52-week high today of $76.92. So far today approximately 576,000 shares have been exchanged, as compared to an average 30-day volume of 5.6 million shares.
Over the past year, Bristol-Myers Squibb has traded in a range of $51.82 to $76.92 and is now at $76.67, 48% above that low. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 1.0%.
Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
Bristol-Myers Squibb (NYSE:BMY) is currently priced 5.7% above its average consensus analyst price target of $72.33. The stock should discover initial support at its 50-day moving average (MA) of $66.29 and subsequent support at its 200-day MA of $64.47.
SmarTrend recommended that subscribers consider buying shares of Bristol-Myers Squibb on April 5th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $66.20. Since that recommendation, shares of Bristol-Myers Squibb have risen 15.7%. We continue to monitor BMY for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows Bristol-Myers Squibb